All enrolled patients provided written informed consent prior to the FMT procedure and their clinical data and stool samples were collected. Eligible patients were adults (≥18 years) and required to have documentation of typical histopathology for IBD with colonic involvement and a confirmed diagnosis of at least three or more documented rCDI with typical laboratory findings. The study protocol conformed to the ethical guidelines of the Institutional Ethical Review Committee of the Research Institute for Gastroenterology and Liver Diseases at Shahid Beheshti University of Medical Sciences (Project No. IR.SBMU.RIGLD.REC.1398.036).
Free full text: Click here